Vaccine

Age

Recommendations

Hib (Haemophilus influenzae type b) vaccine

6 weeks to <5 years

≥5 years

  • If the person has never received a Hib vaccine dose, give a single dose of Hib-containing vaccine.
  • If the person has not completed their primary course of Hib vaccine, give a single dose of Hib-containing vaccine.
  • If the person has completed their Hib vaccination course , they do not need extra or repeat doses.

Influenza vaccine

6 months to <3 years

  • Give 2  doses (0.25 mL each), 4 weeks apart, in the 1st year of vaccination.
  • Give 1  dose (0.25 mL) in subsequent years.

3 to <9 years

  • Give 2  doses (0.5 mL each), 4 weeks apart, in the 1st year of vaccination.
  • Give 1  dose (0.5 mL) in subsequent years.

≥9 years

  • Give 1  dose (0.5 mL) every year.
  • If people with asplenia have had a solid organ or haematopoietic stem cell transplant, they need 2 doses of influenza vaccine during their 1st year of influenza vaccination after transplantation.

Meningococcal vaccines

≥2 months

Pneumococcal vaccines

≤12 months
  • Give a 3-dose primary course of 13vPCV, with a 4th dose of 13vPCV at age 12 months. 
  • Give a single dose of 23vPPV at age 4 years and another dose of 23vPPV, at least 5 years later.
≥12 months -5 yrs
≥5 years
  • If the condition is newly diagnosed or the person has never received a dose of 13vPCV due to the presence of the risk condition, give a single dose of 13vPCV,  followed by 2 doses of 23vPPV (as below).
  • The recommended interval between a 13vPCV dose and a subsequent 23vPPV dose is 12 months (an interval of 2–12 months acceptable). The recommended minimum interval between any two 23vPPV doses is 5 years.
  • There is a maximum limit of 2 doses of 23vPPV.  Therefore, if the person has already received at least 2 doses of 23vPPV, no further 23vPPV doses are required. 
  • If the person has received 1 dose of 23vPPV previously, give the 13vPCV at least 12 months after the previous 23vPPV dose. Give the 2nd 23vPPV dose 12 months after the 13vPCV dose, and at least 5 years after the previous 23vPPV dose, whichever is later.  
  • For Aboriginal and Torres Strait Islander adults aged ≥50 years, these vaccine doses are covered in the routine recommendation and do not need to be repeated.
  • For non-Indigenous adults aged ≥70 years, a dose of 13vPCV is part of the routine recommendation and does not need to be repeated.
Last updated: 
3 June 2020
Last reviewed: 
3 June 2020

Definitions

13vPCV
13-valent pneumococcal conjugate vaccine
23vPPV
23-valent pneumococcal polysaccharide vaccine